BGM Group Ltd. (BGM)

Market Cap	928.05M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	97.22M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,032
Open	9.03
Previous Close	9.58
Day's Range	9.03 - 10.10
52-Week Range	1.78 - 14.78
Beta	1.42
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 13, 2025

About BGM

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jan 12, 2021
• Employees: 298
• Stock Exchange: NASDAQ
• Ticker Symbol: BGM
• Website: https://www.bgmgroupltd.com

Financial Performance

Financial numbers in USD